|
시장보고서
상품코드
2058283
바이오서저리 시장 : 치료법별, 질환별, 지역별Biosurgery Market, By Treatment Type, By Disease Type, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
바이오서저리 시장은 2026년에 191억 1,580만 달러로 추정되며, 2033년까지 298억 9,940만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 6.6%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 191억 1,580만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 6.60% | 2033년 시장 규모 예측: | 298억 9,940만 달러 |
바이오서저리는, 특히 상처 표면 절제술에서, 모든 국소 치료법의 유망한 보조 수단이 됩니다. 바이오서저리에서는 외과적 절개 부위나 상처를 봉합하기 위해 천연, 합성 또는 반합성 소재가 사용됩니다. 바이오서저리 제품은 일반적으로 외과적 절개 부위의 봉합을 돕고 조직의 회복을 촉진하는 천연, 합성 또는 반합성 물질로 구성되어 있습니다.
시장 역학
심혈관질환 유병률의 증가, 고령 인구 증가, 첨단 수술기구 및 기기의 도입 확대, 연구 개발 증가, 건강에 대한 인식 제고, 그리고 의료 인프라 확충은 예측 기간 동안 전 세계 바이오서저리 시장의 성장을 견인할 것으로 예상되는 주요 요인입니다.
예를 들어, 영국심장재단(British Heart Foundation)의 '영국 팩트시트(2022년 8월)'에 따르면, 2021년 기준 영국에는 어떤 형태의 심장·순환기 질환을 앓고 있는 사람이 760만 명 이상입니다. 또한, 2020년 1월, 테르모는 EMEA 시장에서 'AQUABRID'라는 이름의 외과용 실란트를 출시했습니다. AQUABRID는 대동맥 수술을 위해 특별히 개발된 새로운 외과용 실란트입니다. 심장 수술 중 혈액 응고가 억제된 상태에서도 안전하고 효과적으로 지혈을 할 수 있습니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 기업의 주요 정보, 제품 포트폴리오, 주요 성과, 재무 실적, 전략 등의 지표를 바탕으로 전 세계 바이오서저리 시장의 주요 기업 개요을 작성하고 있습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 바이오서저리 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 바이오서저리 시장 : 치료 유형별, 2021-2033년
제5장 세계의 바이오서저리 시장 : 질환 유형별, 2021-2033년
제6장 세계의 바이오서저리 시장 : 지역별, 2021-2033년
제7장 경쟁 구도
제8장 섹션
KSM 26.06.19Biosurgery Market is estimated to be valued at USD 19,115.8 Mn in 2026 and is expected to reach USD 29,899.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 19,115.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.60% | 2033 Value Projection: | USD 29,899.4 Mn |
Biosurgery is promising adjunct to the whole spectrum of topical treatment methods, in particular for debridement. Biosurgery involves natural, synthetic, or semi-synthetic materials to seal surgical incisions and wounds. Biosurgery products typically consist of natural, synthetic, or semi-synthetic materials that help seal surgical incisions and facilitate tissue repairs.
Market Dynamics
Increase in prevalence of cardiovascular diseases, growing geriatric population, rise in adoption of advanced surgical tools and devices, increase in research & development, rising health awareness, and developing healthcare infrastructure are major factors expected to propel growth of the global biosurgery market during the forecast period.
For instance, according to the British Heart Foundation, United Kingdom Factsheet (August 2022), more than 7.6 million people are living in the United Kingdom in 2021 with some kind of heart and circulatory diseases. Moreover, in January 2020, Terumo launched its surgical sealant named AQUABRID in the EMEA market. AQUABRID is a new surgical sealant specially developed for aortic procedures. It is safe and effective in achieving hemostasis, even when blood coagulation is inhibited during cardiac surgery.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global biosurgery market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Betatech Medical, Hemostasis LLC, CryoLife Inc., CSL Limited, Medtronic PLC, Johnson & Johnson, B.Braun Melsungen AG, Baxter International Inc., Integra Lifesciences Holdings Corporation, and Becton, Dickinson and Company (CR Bard), among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global biosurgery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biosurgery market.
Market Segmentation
- By Treatment Type Insights (Revenue, USD Mn, 2021 - 2033)
- Hemostatic Agents
- Bone-graft Substitutes
- Surgical Sealants and Adhesives
- Soft-tissue Attachments
- Adhesion Barriers
- Staple Line Reinforcement
- By Disease Type Insights (Revenue, USD Mn, 2021 - 2033)
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Gynecological Surgery
- Other Applications
- By Region Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players in the Biosurgery Market
- Betatech Medical
- Hemostasis LLC
- CryoLife Inc.
- CSL Limited
- Medtronic PLC
- Johnson & Johnson
- Braun Melsungen AG
- Baxter International Inc.
- Integra Lifesciences Holdings Corporation
- Becton, Dickinson and Company (CR Bard)
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Disease Type
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- High prevalence of heart diseases and growing geriatric population
- Lack of awareness among people about biosurgery
- Increasing adoption of advanced surgical tools and devices
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Biosurgery Market, By Treatment Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hemostatic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Bone-graft Substitutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Surgical Sealants and Adhesives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Soft-tissue Attachments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Adhesion Barriers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Staple Line Reinforcement
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Biosurgery Market, By Disease Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Orthopedic Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- General Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Neurological Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Cardiovascular Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Gynecological Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Biosurgery Market, By Geography, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021-2033, (USD Mn)
- South Africa
- North Africa
- Central Africa
7. Competitive Landscape
- Betatech Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hemostasis LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CryoLife Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CSL Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- B.Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Integra Lifesciences Holdings Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company (CR Bard)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
8. Section
- Research Methodology
- About us
